It isn’t a new tequila and you definitely can’t braai with it. ASP Isotopes makes enriched isotopes for medicine, chips and nuclear energy, mostly from Pretoria, and it just added a JSE listing to its Nasdaq one. Science fiction meets Sandton, with a Pretoria accent.
By The Money Maze | Listen to the episode: Spotify
New listings on the JSE are rarer than a quiet taxi rank, so when one arrives with lab coats instead of hard hats, people notice.
On Wednesday 27 August 2025, ASP Isotopes started trading on the JSE Main Board under the share code ISO. The JSE said it was the third new listing of 2025, taking the exchange to 276 listed companies.
What does ASP Isotopes do?
Isotopes are versions of the same chemical element with slightly different weights. Some of them are very useful, and very hard to separate. ASP Isotopes enriches them: it concentrates the useful version so industry can use it.
It uses two technologies. Its own Aerodynamic Separation Process, ASP, for lighter elements, and a Quantum Enrichment technology it’s developing, aimed partly at nuclear energy. The focus areas:
- Healthcare: isotopes such as carbon-14 for drug development, and ytterbium-176, which is used to make a cancer treatment isotope.
- Semiconductors and quantum computing: silicon-28, prized for next-generation chips.
- Nuclear energy: enriched fuels for future reactors.
Not products you’ll find at Checkers. Essential ingredients for some of the most advanced industries on earth.
The Pretoria connection
Here’s the local angle. ASP Isotopes is a US-registered company with its primary listing on the Nasdaq, but its three enrichment facilities are in Pretoria. Its pre-listing statement said it had finished commissioning and was starting commercial production at its carbon-14 and silicon-28 plants, and producing commercial samples of highly enriched ytterbium-176.
So while American investors see a futuristic isotope stock, South Africans can point to plants down the road and say, “That’s ours.”
Secondary listing explained
ASP’s JSE listing is a secondary, or inward, listing. The primary listing stays on the Nasdaq, and the number of shares in issue doesn’t change. It was done by introduction, which means no new money was raised. 91,413,109 shares were listed on the JSE, classified under speciality chemicals.
Why bother? Two reasons. First, access: South Africans can buy it in rands, without opening an offshore account. Second, a deal: ASP was buying Renergen, the JSE-listed helium and gas company, and the pre-listing statement said the JSE listing was in anticipation of that scheme, so ASP shares listed here could be used to pay Renergen shareholders.
How dual-listed shares behave
We’ve seen plenty of companies listed in two places: Prosus in Amsterdam and Johannesburg, Anglo American in London and Johannesburg. Usually the primary market drives the price and the secondary market follows, because arbitrage traders step in when prices drift apart.
But early days can be messy. On debut, Business Report noted the JSE price was trading at an 18% premium to the previous Nasdaq close, with thin volumes and clear demand. In the days that followed, the JSE shares ran much higher, which is what the episode title is about. When local investors are starved of exciting new stocks and only a small number of shares sit on the JSE register, prices can sprint well ahead of the main market. That’s a liquidity effect, not a sudden discovery of hidden value, and it tends to correct.
ASP Isotopes bull case
One share with exposure to healthcare, semiconductors and nuclear energy. Proprietary technology, built and run largely in South Africa. Plants already in commissioning and early production rather than just PowerPoints. Plans for more enrichment facilities in South Africa and elsewhere. And the JSE gets a rare, genuinely different listing.
ASP Isotopes bear case
It describes itself as a development-stage company. Scaling isotope production is expensive and slow, and cash burn is real. If funding dries up, progress slows. Customers and contracts still need to prove the market is big enough. The share has been extremely volatile on the Nasdaq, and a thinly traded secondary listing can swing even harder. Exciting, yes. Safe, no.
What to watch
- Cash burn versus revenue as production ramps up.
- Whether silicon-28 and ytterbium-176 turn into steady commercial sales.
- New isotopes and new plants arriving on schedule.
- The gap between the JSE and Nasdaq prices, which tells you whether the local hype has cooled.
Stokvel Starter Pack
- Secondary listing: an extra listing on another exchange. The primary market still leads.
- Listing by introduction: shares listed without raising new money.
- Isotope enrichment: concentrating the useful version of an element.
- Arbitrage: traders buying in the cheap market and selling in the expensive one, which pulls prices together.
- Development-stage company: still building the business. Expect volatility and capital raises.
Takeaway: A JSE listing gives South Africans easy access to a homegrown science story. It doesn’t make the science easier. Don’t bet the boerie money on first-week fireworks.
Want the full braai version? Listen on Spotify. And if you’d like the Maze in your inbox, join the free Maze Mail list.
More from The Money Maze
- Why Elon Musk Left South Africa: What It Means for the JSE
- Dual Listings, Delistings and Why SA Companies Pack for London
- Trading Volume, Bid/Ask Spread and Liquidity Explained
- JSE Suspensions, Delistings and Vanishing Shares Explained
Sources
- JSE welcomes ASP Isotopes secondary listing, JSE, 27 Aug 2025.
- Abridged pre-listing statement, ASP Isotopes on SENS, 8 Aug 2025.
- ASP Isotopes announces expected commencement of dual listing on the JSE, ASP Isotopes, 8 Aug 2025.
- ASP Isotopes lists on the JSE as its South African expansion continues, Business Report, 27 Aug 2025.
This is not financial advice.
